1. Home
  2. UNTY vs KROS Comparison

UNTY vs KROS Comparison

Compare UNTY & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unity Bancorp Inc.

UNTY

Unity Bancorp Inc.

HOLD

Current Price

$55.08

Market Cap

538.6M

Sector

Finance

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.24

Market Cap

584.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNTY
KROS
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
538.6M
584.9M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
UNTY
KROS
Price
$55.08
$11.24
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$65.00
$21.86
AVG Volume (30 Days)
25.1K
302.8K
Earning Date
04-14-2026
05-06-2026
Dividend Yield
1.23%
N/A
EPS Growth
39.66
146.00
EPS
1.40
N/A
Revenue
N/A
$243,864,000.00
Revenue This Year
$12.14
N/A
Revenue Next Year
$9.56
$2,751.79
P/E Ratio
$38.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$41.67
$9.79
52 Week High
$57.30
$22.55

Technical Indicators

Market Signals
Indicator
UNTY
KROS
Relative Strength Index (RSI) 61.77 49.43
Support Level $50.54 $10.64
Resistance Level $57.03 $12.43
Average True Range (ATR) 1.17 0.70
MACD 0.19 -0.05
Stochastic Oscillator 99.85 61.98

Price Performance

Historical Comparison
UNTY
KROS

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. The Company has elected to become a financial holding company pursuant to regulations of the Board of Governors of the Federal Reserve System (the FRB). The Company's primary business is ownership and supervision of the Bank. The Company and the Bank derive a majority of their revenue from net interest income (i.e., the difference between the interest received on loans and securities and the interest paid on deposits and borrowings). The Company, through the Bank, conducts a traditional and community-oriented commercial banking business and services, personal and business checking accounts, time deposits, money market accounts, savings accounts, credit cards, automated teller service, and others.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: